Abstract:The current study aimed to synthesize seven new metal coordination complexes ( Q1–Q7 ) with potential biomedical applications. Novel mononuclear, polynuclear and mixed-ligand coordination compounds of the elements, cadmium( II ) and silver( I ) derived from a pyridine containing ligand (2,4,6-tris-(2-pyridyl)-1,3,5-triazine ( TPT )) have been synthesized successfully with the general formulae [Cd( TPT )Cl 6 ]·H 2 O and [Ag x ( TPT ) y (L) 2 (ClO 4 )](ClO 4 ) z ( x = 1,2,3, y = 1,2,3, L = PPh 3 or phen, z = 1,2). The structural features were fully characterized using various spectroscopic techniques, such as infrared, ultraviolet-visible spectroscopy, 1D and 2D-NMR ( 1 H, 13 C, 31 P, 1 H– 1 H COSY and 1 H– 13 C HSQCAD), CHN analysis, molar conductance ( Λ ), thermogravimetric analysis (TGA), and powder X-ray diffraction analysis. The structure of complex Q6 was also confirmed by single-crystal X-ray analysis. The luminescence and electrochemical properties of complexes, in solution, have been studied. X-ray crystallographic determination of the [Ag( TPT )(PPh 3 ) 2 ]ClO 4 ·EtOH ( Q6 ) complex shows that the Ag + cation is bonded to one tridentate TPT ligand through NNN set of donor atoms and two triphenylphosphine ligands, giving the Ag + a distorted trigonal bipyramidal geometry. X-ray powder diffraction analysis showed that metal complexes Q3 , Q6 and Q7 display crystalline peaks. The complexes were evaluated for their in vitro antibacterial efficacy against various bacterial and fungal species. The in vitro efficacy against the MCF-7 human breast cancer cell line was assessed to determine the anticancer activities. The tri-nuclear silver complex Q3 shows great potential as a therapeutic candidate for treating breast cancer, since it exhibits a half-maximal inhibition concentration (IC 50 ) of 13.45 ± 0.9 μM. Molecular docking simulations were also carried out to evaluate the interaction strength and properties of the metal complexes with selected cancer and bacteria relevant proteins namely cyclin-dependent kinase 2 (CDK2), cyclin-dependent kinase 6 (CDK6), signal transducer and activator of transcription 3 (STAT3), and beta-lactamases from Escherichia coli and Staphylococcus aureus .

A novel cadmium(II) complex of bipyridine derivative: synthesis, X-ray crystal structure, DNA-binding and antibacterial activities

Synthesis and Characterization of a New Cadmium Framework Based on 2,5-Dimethyl-1,3,4-thiodiazole and Dicyanamide Anion

Single Crystal, Spectroscopic Measurement, Quantum Chemical Studies, and Antimicrobial Potency of a new Cadmium Compound as a Potential Candidate for Therapeutic Antibacterial drug Development

Two Novel Cadmium(ii) Complexes with Demethylcantharate and Polypyridyl: Crystal Structure, Interactions with DNA and Bovine Serum Albumin

Synthesis and characterization of some new Cd(II) and Zn(II) macrocyclic Schiff base complexes derived from cyclocondensation of three new linear aromatic (N4) amines and 2,6-diacetylpyridine. Crystal structure and biological activity studies

Synthesis and Crystal Structure of a Cadmium(II) Complex with 2,2′-Diamino-4,4′-bis-1,3-thiazole

Novel metal(II) complexes with pyrimidine derivative ligand: synthesis, multi-spectroscopic, DNA binding/cleavage, molecular docking with DNA/BSA, and antimicrobial studies

Syntheses, Crystal Structures, And Antimicrobial Activities Of Nickel(Ii) And Cadmium(Ii) Complexes With 4-Methylsulfonyl Cinnamate And Diamines

Crystal Structure, Photophysical Properties and Antibacterial Activity of a Cd(II) Complex with Trans-2,3,4-Trimethoxycinnamic Acid and 4,4′-Bipyridine Ligands

New penta‐coordinated cadmium(II) complexes: Synthesis, Characterization, Thermal, Antimicrobial, Antioxidant and Cytotoxicity Properties

Synthesis, characterization, and biological activity of cadmium (II) and antimony (III) complexes based on 2-acetylpyrazine thiosemicarbazones

Exploring Novel Cd(II) Complexes with 5-Methyl-4-Imidazolecarboxaldehyde: Synthesis, Structure, Computational Insights, and Affinity to DNA through switchSense Methodology

Cadmium oxide nanoparticles from new organometallic Cd(II)-Schiff base complex and in vitro biological potentials: dual S. aureus and E. coli DNA gyrase inhibition by the precursors via in silico binding modes' study

Synthesis and preliminary biological evaluation of antibacterial and antifungal 5-arylidene tetramic acid-cadmium(II) complexes

Cobalt (II) complex with novel unsymmetrical tetradentate Schiff base (ON) ligand: in vitro cytotoxicity studies of complex, interaction with DNA/protein, molecular docking studies, and antibacterial activity

Cadmium and silver complexes of a pyridine containing ligand: syntheses, structural studies, biological activity and docking studies

Crystallographic, spectroscopic, and antimicrobial activities of nickel(II) and cadmium(II) complexes with N -heterocycle: TD/DFT calculations and Hirshfeld surface analysis

Co (II), Ni (II), and Cu (II) ternary complexes with 2,6‐pyridinedicarboxylic acid: Thermal decomposition, DNA interaction, and biological activity studies

Synthesis, crystal structure, hirshfeld surface analysis, and computational studies of dimeric and polymeric cadmium complexes

Synthesis, X-ray molecular structure and QTAIM and NCI-RDG theoretic studies of a new cadmium (II) (4′4 diaminodiphenylmethane) (meso-arylporphyrin) coordination compound

Synthesis, crystal structure and antitumor activity of a new coordination polymer [cd(c14h10n3o5) 2(c5h5n)2]n